Logo image of SRE

SEMPRA (SRE) Stock Fundamental Analysis

USA - NYSE:SRE - US8168511090 - Common Stock

90.71 USD
-0.31 (-0.34%)
Last: 11/20/2025, 8:28:06 PM
90.71 USD
0 (0%)
After Hours: 11/20/2025, 8:28:06 PM
Fundamental Rating

3

Taking everything into account, SRE scores 3 out of 10 in our fundamental rating. SRE was compared to 26 industry peers in the Multi-Utilities industry. SRE has an average financial health and profitability rating. SRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SRE was profitable.
SRE had a positive operating cash flow in the past year.
In the past 5 years SRE has always been profitable.
Each year in the past 5 years SRE had a positive operating cash flow.
SRE Yearly Net Income VS EBIT VS OCF VS FCFSRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.97%, SRE is doing worse than 84.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.77%, SRE is doing worse than 84.62% of the companies in the same industry.
With a Return On Invested Capital value of 2.94%, SRE is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for SRE is in line with the industry average of 3.96%.
Industry RankSector Rank
ROA 1.97%
ROE 6.77%
ROIC 2.94%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SRE Yearly ROA, ROE, ROICSRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SRE's Profit Margin of 15.38% is amongst the best of the industry. SRE outperforms 80.77% of its industry peers.
SRE's Profit Margin has improved in the last couple of years.
SRE has a Operating Margin of 22.51%. This is in the better half of the industry: SRE outperforms 65.38% of its industry peers.
In the last couple of years the Operating Margin of SRE has declined.
Industry RankSector Rank
OM 22.51%
PM (TTM) 15.38%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SRE Yearly Profit, Operating, Gross MarginsSRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

SRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SRE has been increased compared to 1 year ago.
SRE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SRE is higher compared to a year ago.
SRE Yearly Shares OutstandingSRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SRE Yearly Total Debt VS Total AssetsSRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

SRE has an Altman-Z score of 1.05. This is a bad value and indicates that SRE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.05, SRE belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
A Debt/Equity ratio of 1.02 is on the high side and indicates that SRE has dependencies on debt financing.
SRE has a Debt to Equity ratio of 1.02. This is amongst the best in the industry. SRE outperforms 96.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACC0.44
WACC6.71%
SRE Yearly LT Debt VS Equity VS FCFSRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SRE has a Current Ratio of 1.59. This is a normal value and indicates that SRE is financially healthy and should not expect problems in meeting its short term obligations.
SRE has a better Current ratio (1.59) than 96.15% of its industry peers.
SRE has a Quick Ratio of 1.56. This is a normal value and indicates that SRE is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.56, SRE belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.56
SRE Yearly Current Assets VS Current LiabilitesSRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.24% over the past year.
SRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.31% yearly.
SRE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.14%.
SRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.04% yearly.
EPS 1Y (TTM)16.24%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%24.72%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%13.51%

3.2 Future

Based on estimates for the next years, SRE will show a small growth in Earnings Per Share. The EPS will grow by 6.96% on average per year.
Based on estimates for the next years, SRE will show a decrease in Revenue. The Revenue will decrease by -0.54% on average per year.
EPS Next Y-0.85%
EPS Next 2Y5.43%
EPS Next 3Y6.4%
EPS Next 5Y6.96%
Revenue Next Year-11.31%
Revenue Next 2Y-3.91%
Revenue Next 3Y-3.57%
Revenue Next 5Y-0.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SRE Yearly Revenue VS EstimatesSRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SRE Yearly EPS VS EstimatesSRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.36, which indicates a rather expensive current valuation of SRE.
The rest of the industry has a similar Price/Earnings ratio as SRE.
The average S&P500 Price/Earnings ratio is at 25.07. SRE is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 17.66 indicates a rather expensive valuation of SRE.
Based on the Price/Forward Earnings ratio, SRE is valued a bit more expensive than 65.38% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.08. SRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.36
Fwd PE 17.66
SRE Price Earnings VS Forward Price EarningsSRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SRE is valued expensively inside the industry as 92.31% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.89
SRE Per share dataSRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.43%
EPS Next 3Y6.4%

3

5. Dividend

5.1 Amount

SRE has a Yearly Dividend Yield of 2.80%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.19, SRE's dividend is way lower than its industry peers. On top of this 80.77% of the companies listed in the same industry pay a better dividend than SRE!
SRE's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

The dividend of SRE decreases each year by -9.71%.
SRE has been paying a dividend for at least 10 years, so it has a reliable track record.
As SRE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-9.71%
Div Incr Years7
Div Non Decr Years7
SRE Yearly Dividends per shareSRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

76.67% of the earnings are spent on dividend by SRE. This is not a sustainable payout ratio.
DP76.67%
EPS Next 2Y5.43%
EPS Next 3Y6.4%
SRE Yearly Income VS Free CF VS DividendSRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SRE Dividend Payout.SRE Dividend Payout, showing the Payout Ratio.SRE Dividend Payout.PayoutRetained Earnings

SEMPRA

NYSE:SRE (11/20/2025, 8:28:06 PM)

After market: 90.71 0 (0%)

90.71

-0.31 (-0.34%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners91.76%
Inst Owner Change3.45%
Ins Owners0.04%
Ins Owner Change-18.55%
Market Cap59.19B
Revenue(TTM)13.71B
Net Income(TTM)2.11B
Analysts77.14
Price Target98.24 (8.3%)
Short Float %2.1%
Short Ratio3.5
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP76.67%
Div Incr Years7
Div Non Decr Years7
Ex-Date12-11 2025-12-11 (0.645)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.33%
Min EPS beat(2)4.16%
Max EPS beat(2)20.49%
EPS beat(4)3
Avg EPS beat(4)6.38%
Min EPS beat(4)-7.18%
Max EPS beat(4)20.49%
EPS beat(8)4
Avg EPS beat(8)0.32%
EPS beat(12)8
Avg EPS beat(12)2.78%
EPS beat(16)12
Avg EPS beat(16)4.05%
Revenue beat(2)1
Avg Revenue beat(2)1.51%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)7.1%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-14.67%
Max Revenue beat(4)7.1%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)2
Avg Revenue beat(12)-5.38%
Revenue beat(16)6
Avg Revenue beat(16)-1.3%
PT rev (1m)12.53%
PT rev (3m)17.16%
EPS NQ rev (1m)-3.64%
EPS NQ rev (3m)-7.37%
EPS NY rev (1m)0.22%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)-3.39%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)1.71%
Revenue NY rev (3m)-3.8%
Valuation
Industry RankSector Rank
PE 18.36
Fwd PE 17.66
P/S 4.32
P/FCF N/A
P/OCF 12.48
P/B 1.9
P/tB 1.9
EV/EBITDA 15.89
EPS(TTM)4.94
EY5.45%
EPS(NY)5.14
Fwd EY5.66%
FCF(TTM)-9.02
FCFYN/A
OCF(TTM)7.27
OCFY8.01%
SpS21.01
BVpS47.78
TBVpS47.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number72.87
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 6.77%
ROCE 3.55%
ROIC 2.94%
ROICexc 2.94%
ROICexgc 2.94%
OM 22.51%
PM (TTM) 15.38%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexgc growth 3Y-8.37%
ROICexgc growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Debt/EBITDA 5.6
Cap/Depr 411.78%
Cap/Sales 77.51%
Interest Coverage 2.32
Cash Conversion 83.66%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.56
Altman-Z 1.05
F-Score5
WACC6.71%
ROIC/WACC0.44
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.24%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%24.72%
EPS Next Y-0.85%
EPS Next 2Y5.43%
EPS Next 3Y6.4%
EPS Next 5Y6.96%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%13.51%
Revenue Next Year-11.31%
Revenue Next 2Y-3.91%
Revenue Next 3Y-3.57%
Revenue Next 5Y-0.54%
EBIT growth 1Y18.88%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year58.5%
EBIT Next 3Y22.25%
EBIT Next 5Y13.97%
FCF growth 1Y-58.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.56%
OCF growth 3Y8.5%
OCF growth 5Y9.71%

SEMPRA / SRE FAQ

What is the fundamental rating for SRE stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRE.


What is the valuation status of SEMPRA (SRE) stock?

ChartMill assigns a valuation rating of 1 / 10 to SEMPRA (SRE). This can be considered as Overvalued.


Can you provide the profitability details for SEMPRA?

SEMPRA (SRE) has a profitability rating of 4 / 10.


Can you provide the financial health for SRE stock?

The financial health rating of SEMPRA (SRE) is 4 / 10.


What is the expected EPS growth for SEMPRA (SRE) stock?

The Earnings per Share (EPS) of SEMPRA (SRE) is expected to decline by -0.85% in the next year.